Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

Elisabetta Bugianesi(University of Turin), Mario Rizzetto(University of Turin)

Diabetologia

March 3, 2005

10.1007/s00125-005-1682-x

Cited by 759

Related Papers

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

|Hepatology|2023|2.9k

Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome

|Hepatology|2003|2.7k

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

|Journal of Hepatology|2023|2.7k

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

|Journal of Hepatology|2024|1.6k

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

|The Lancet|2019|1.2k